본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

호흡기계 작용 약물의 치료군 중복처방 평가기준 개발

이용수 24

영문명
Therapeutic Duplication Criteria Development of Respiratory System Drugs
발행기관
대한약학회
저자명
최경업(Kyung Eob Choi) 손현순(Hyun Soon Sohn) 김남효(Nam Hyo Kim) 신현택(Hyun Taek Shin) 이영숙(Young Sook Lee)
간행물 정보
『약학회지』제56권 제2호 (2012년), 126~135쪽, 전체 10쪽
주제분류
의약학 > 기타의약학
파일형태
PDF
발행일자
2012.04.30
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Purpose: To develop therapeutic duplication criteria for the drugs used for respiratory diseases. Method: Therapeutic duplication was defined as "more than 2 drug ingredient-usage in which each has the same therapeutic effect and combination therapy does not confer additional therapeutic benefit". Respiratory system drugs approved in Korea were examined for the study. The WHO’s Anatomical Therapeutic Chemical Classification System was used for grouping of the corresponding drug ingredients. The principles and recommendations on combination usage or multiple drug regimens were reviewed by using the clinical practice guidelines, textbooks, product labelings, and clinical articles. Clinical expert group consultation was performed and expert opinions were incorporated into the final criteria. Results: Nine hundred sixty two drug products with Korean Food and Drug Administration classification codes of 141, 149, 222, and 229 were evaluated, of which 87 active ingredients were composed. The drug ingredients were classified into 12 groups (antihistamines, oral nasal decongestants, leukotriene receptor antagonists, inhaled anticholinergics, inhaled corticosteroids, oral β2-agonists, long-acting β2-agonists, short-acting β2-agonists, xanthines, antiallergics, mucolytics and cough suppressants). The use of more than 2 drug ingredients including the same group was therapeutic duplication, and thus combination should be recommended not to be used. Conclusion: Twelve drug groups were identified as therapeutic duplication criteria. Combination therapy within each group should not be used otherwise therapeutic benefits outweigh potential risks.

목차

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

최경업(Kyung Eob Choi),손현순(Hyun Soon Sohn),김남효(Nam Hyo Kim),신현택(Hyun Taek Shin),이영숙(Young Sook Lee). (2012).호흡기계 작용 약물의 치료군 중복처방 평가기준 개발. 약학회지, 56 (2), 126-135

MLA

최경업(Kyung Eob Choi),손현순(Hyun Soon Sohn),김남효(Nam Hyo Kim),신현택(Hyun Taek Shin),이영숙(Young Sook Lee). "호흡기계 작용 약물의 치료군 중복처방 평가기준 개발." 약학회지, 56.2(2012): 126-135

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제